Zomedica Announces $7 Million Second Tranche Closing of Preferred Shares
June 10, 2019 06:00 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., June 10, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company,...
Zomedica Announces Achievement of Product Development Milestones on its TRUFORMA™ Point-of-Care Diagnostic Platform
May 21, 2019 06:55 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., May 21, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, today announced that...
Zomedica Announces First Quarter 2019 Financial Results
May 10, 2019 17:21 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., May 10, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company, today...
Zomedica Announces Private Placement of Preferred Shares
May 10, 2019 06:00 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., May 10, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company,...
Zomedica Announces 2018 Annual Meeting Results
August 15, 2018 16:15 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company,...
Zomedica Pharmaceuticals Corp. Announces Second Quarter 2018 Financial Results
August 09, 2018 16:01 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company,...
Zomedica to Participate in the Bank of America Merrill Lynch Animal Health Summit
February 20, 2018 06:55 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company,...
Zomedica Pharmaceuticals Corp. Enters into License and Supply Agreement with Celsee, Inc. for Cancer Liquid Biopsy Platform
December 21, 2017 06:55 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and diagnostic company,...
Zomedica Announces Achievement of Therapeutic Development Milestones
December 12, 2017 06:55 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and diagnostic company,...
Zomedica Pharmaceuticals Corp. Registration Statement Declared Effective by U.S. Securities and Exchange Commission
November 20, 2017 18:51 ET
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Nov. 20, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (NYSE American:ZOM) (Zomedica or the Company), a veterinary pharmaceutical and health care solutions...